Cat. No JK439871_100_G
J&K Chemical

Product Information

Product Name
Fluoxetine, 97%
Brand Name
J&K
Product Number
439871
CAS
54910-89-3
Molecular Formula
C17H18F3NO
Molecular Weight
309.33
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
3386
IUPAC Name
N-methyl-3-phenyl-3-4-(trifluoromethyl)phenoxypropan-1-amine
InChI Key
RTHCYVBBDHJXIQ-UHFFFAOYSA-N
SMILES
CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F

References Data Source From Pubchem

Efficacy and safety of dextromethorphan/quinidine in treating pseudobulbar affect in neurological disorders: A systematic review and dose-classified network meta-analysis

Publication Name: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Publication Date: 2026-05-12
DOI: 10.1007/s10072-025-08640-7|10.1007/s10072-026-09078-1

Title Not Available

Publication Name: MMW Fortschritte der Medizin
Publication Date: 2026-05
DOI: 10.1007/s15006-025-4601-8|10.1007/s15006-025-4696-y|10.1007/s15006-025-4723-z|10.1007/s15006-025-4888-5|10.1007/s15006-025-5079-0|10.1007/s15006-025-5194-y|10.1007/s15006-025-5360-2|10.1007/s15006-025-5467-5|10.1007/s15006-025-5530-2|10.1007/s15006-026-5942-7|10.1007/s15006-026-5943-6|10.1007/s15006-026-5983-y

[Galactorrhea with euprolactinemia under SSRI treatment]

Publication Name: Der Nervenarzt
Publication Date: 2026-05
DOI: 10.1007/s00115-025-01848-0

Escitalopram accelerated aging via impaired IIS/autophagy signaling pathway

Publication Name: GeroScience
Publication Date: 2026-03-05
DOI: 10.1007/s11357-026-02190-2

Breaking the Barrier of Brain Disease Therapeutics: Advocating Targeted Drug Delivery for Improved Neuro-Resident Interventions

Publication Name: AAPS PharmSciTech
Publication Date: 2026-03-04
DOI: 10.1208/s12249-026-03386-7

Fluoxetine, 97%

Just added to your wishlist:
My Wishlist
You've just added this product to the cart:
Go to cart page